e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of night-time dyspnoea in COPD and its implications for prognosis
Lange Peter, Marott Jacob Louis, Vestbo Jørgen, Nordestgaard Børge Grønne
Source:
Eur Respir J 2014; 43: 1590-1598
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lange Peter, Marott Jacob Louis, Vestbo Jørgen, Nordestgaard Børge Grønne. Prevalence of night-time dyspnoea in COPD and its implications for prognosis. Eur Respir J 2014; 43: 1590-1598
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Identification of COPD patient factors associated with nighttime and early morning symptoms
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Assessing COPD profiles and outcomes by dyspnoea severity
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Impact of nighttime and early morning symptoms on HRQoL and work productivity of COPD patients
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
An exploration of dyspnoea and determinants in patients with COPD
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020
Prevalence, predictors and impact of nocturnal hypoxemia in non-apnoeic patients with COPD
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Nocturnal hypoxaemia in COPD. Prevalence and clinical characteristics.
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Usefulness and relationship of clinical dyspnoea ratings with health status in chronic obstructive pulmonary disease patients
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Mechanisms, measurement and management of exertional dyspnoea in asthma
Source: Eur Respir Rev, 26 (144) 170015; 10.1183/16000617.0015-2017
Year: 2017
What are the consequences of chronic cough and expectoration for health status among patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 577s
Year: 2003
Severe exertional dyspnoea in COPD: Implications for exercise tolerance and survival
Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD
Year: 2021
Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Determinants of dyspnea in stable COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011
Overdiagnosis of COPD and asthma among elderly with chronic dyspnea
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021
Impact of exacerbation of COPD on anxiety and depression symptoms and dyspnea in the activities of daily living
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015
Mechanisms of exertional dyspnoea in symptomatic smokers without COPD
Source: Eur Respir J 2016; 48: 694-705
Year: 2016
Measuring exertional dyspnoea in health and disease
Source: International Congress 2016 – PG3 Advanced respiratory and cardiovascular exercise testing
Year: 2016
Prevalence of hyperinflation and its reversibility in asthma patients with poorly controlled disease or significant dyspnea
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
The clinical management of exertional dyspnoea in patients with cardiorespiratory diseases
Source: Research Seminar 2012 - Dyspnoea: multidimensional and multidisciplinary
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept